ALUSTAL EUROPEAN DUST MITE EXTRACT european house dust mite 10.0 IR/mL injection suspension vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

alustal european dust mite extract european house dust mite 10.0 ir/ml injection suspension vial

stallergenes australia pty ltd - european house dust mite extract, quantity: 10 ir/ml - injection, suspension - excipient ingredients: mannitol; aluminium hydroxide hydrate; sodium chloride; phenol; water for injections - treatment of patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis, with or without associated asthma.

Cerezyme Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

cerezyme

pharmacy retailing (nz) ltd t/a healthcare logistics - imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells);   - powder for infusion - 40 u/ml - active: imiglucerase 400 u (per 10 ml -biological product from recombinant cho cells)   excipient: citric acid monohydrate mannitol nitrogen polysorbate 80 sodium citrate dihydrate - cerezyme is indicated for long - term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; b) thrombocytopenia; c) bone disease; d) hepatomegaly or splenomegaly.

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Європейський Союз - англійська - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - pituitary and hypothalamic hormones and analogues - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),

Nardil Австралія - англійська - Department of Health (Therapeutic Goods Administration)

nardil

link medical products pty ltd t/a link pharmaceuticals - phenelzine sulfate -

Hydrea Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

hydrea

link pharmaceuticals ltd - hydroxycarbamide 500mg;   - capsule - 500 mg - active: hydroxycarbamide 500mg   excipient: citric acid dibasic sodium phosphate dodecahydrate erythrosine gelatin   indigo carmine iron oxide yellow lactose monohydrate magnesium stearate opacode black s-1-277002 titanium dioxide   - significant tumour response to hydrea (hydroxyurea) has been demonstrated in chronic myelocytic leukaemia (pretreatment phase and palliative care) and recurrent metastatic or inoperable carcinoma of the ovary. hydrea used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip, and carcinoma of the cervix.

Tadalafil Aristo Pharma 5mg film-coated tablets Мальта - англійська - Medicines Authority

tadalafil aristo pharma 5mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Tadalafil Aristo Pharma 10mg film-coated tablets Мальта - англійська - Medicines Authority

tadalafil aristo pharma 10mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 10 mg - urologicals

Tadalafil Aristo Pharma 20mg film-coated tablets Мальта - англійська - Medicines Authority

tadalafil aristo pharma 20mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals